Shift Bioscience

Cambridge, United Kingdom

Simulation guided target discovery for age-linked diseases

$16.3M raised

Oct 2024

Seed

Biopharma Biotechnology Machine Learning Pharmaceutical

Top Investors

Business Growth FundKindred CapitalF-Prime CapitalIKJ CapitalJonathan Milner

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Shift Bioscience

How much funding has Shift Bioscience raised?

Shift Bioscience has raised $16.3M in total funding. The most recent round was Seed. The last funding was announced in October 2024.

Who are Shift Bioscience's investors?

Shift Bioscience's investors include Business Growth Fund, Kindred Capital, F-Prime Capital, IKJ Capital, Jonathan Milner.

Where is Shift Bioscience headquartered?

Shift Bioscience is headquartered in Cambridge, United Kingdom.

What does Shift Bioscience do?

Simulation guided target discovery for age-linked diseases

What stage is Shift Bioscience at?

Shift Bioscience is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 15, 2024.

MLA

"Shift Bioscience — Funding & Investors." VCBacked, October 15, 2024, https://www.vcbacked.co/company/shift-bioscience. Accessed June 3, 2026.

APA

VCBacked. (2024). Shift Bioscience — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/shift-bioscience

Wikipedia (cite web)

{{cite web |title=Shift Bioscience — Funding & Investors |url=https://www.vcbacked.co/company/shift-bioscience |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 15, 2024.

Similar Companies in Biopharma